T1	HMM 132 170	overall and progression-free survival.
T2	HMM 837 854	Survival analysis
T3	HMM 1103 1116	tumor relapse
T4	HMM 1168 1197	5-year overall survival rates
T5	HMM 1272 1310	5-year progression-free survival rates
T6	HMM 1423 1431	toxicity
T7	HMM 1469 1479	leukopenia
T8	HMM 1484 1502	emesis, compliance
T9	HMM 1689 1713	treatment-related deaths
